DMN:FRA
Diamyd Medical AB
၀.၀၈၀ €
arrow_upward
+၅.၆၇%(+၀.၀၀၄၃) 1D
ဇူ ၃, GMT+၂ ၂၂:၀၀:၀၀ · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DMN...
Open
၀.၀၈ €
High
၀.၀၈ €
Low
၀.၀၈ €
Mkt. cap
၁၆.၅၁ ကုဋေ
Avg. vol.
၁၃၃.၀၀
Volume
၀.၀၀
52-wk high
၁.၈၀ €
52-wk low
၀.၀၅ €
No. of employees
၄၄
Open
၀.၀၈ €
High
၀.၀၈ €
Low
၀.၀၈ €
Mkt. cap
၁၆.၅၁ ကုဋေ
Avg. vol.
၁၃၃.၀၀
Volume
၀.၀၀
52-wk high
၁.၈၀ €
52-wk low
၀.၀၅ €
No. of employees
၄၄
News stories
From sources across the web
TechStock²
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
Rezolve AI (NASDAQ:RZLV) sets $300M buyback as shares swing in holiday week
TechStock²
·
ပြီးခဲ့သည့် ၃၃ မိနစ်
Palo Alto Networks (NASDAQ:PANW) could see staged Israel index move after 14% weekly gain
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ နာရီ
Meet the High-Yield Dividend Stock That's Quietly Crushing the S&P 500 and Nasdaq. Here's Why There's Plenty of Room to Run.
MSN
·
ပြီးခဲ့သည့် ၈ နာရီ
QQQ vs. VOO: Should the Nasdaq-100 or the S&P 500 be your core holding?
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products.
The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB
AI content may include mistakes. Learn more